A Molecular Study of 136 Patients with an Imprinting Defect by El Maarri, Osman et al.
Am. J. Hum. Genet. 72:571–577, 2003
571
Epimutations in Prader-Willi and Angelman Syndromes: A Molecular Study
of 136 Patients with an Imprinting Defect
Karin Buiting,1 Stephanie Groß,1 Christina Lich,1 Gabriele Gillessen-Kaesbach,1
Osman El-Maarri,2 and Bernhard Horsthemke1
1Institut fu¨r Humangenetik, Universita¨tsklinikum Essen, Essen, Germany; and 2Institut fu¨r Experimentelle Ha¨matologie und
Transfusionsmedizin, Friedrich-Wilhelms-Universita¨t, Bonn, Germany
Prader-Willi syndrome (PWS) and Angelman syndrome (AS) are neurogenetic disorders that are caused by the loss
of function of imprinted genes in 15q11-q13. In a small group of patients, the disease is due to aberrant imprinting
and gene silencing. Here, we describe the molecular analysis of 51 patients with PWS and 85 patients with AS
who have such a defect. Seven patients with PWS (14%) and eight patients with AS (9%) were found to have an
imprinting center (IC) deletion. Sequence analysis of 32 patients with PWS and no IC deletion and 66 patients
with AS and no IC deletion did not reveal any point mutation in the critical IC elements. The presence of a faint
methylated band in 27% of patients with AS and no IC deletion suggests that these patients are mosaic for an
imprinting defect that occurred after fertilization. In patients with AS, the imprinting defect occurred on the
chromosome that was inherited from either the maternal grandfather or grandmother; however, in all informative
patients with PWS and no IC deletion, the imprinting defect occurred on the chromosome inherited from the
paternal grandmother. These data suggest that this imprinting defect results from a failure to erase the maternal
imprint during spermatogenesis.
Introduction
Prader-Willi syndrome (PWS [MIM 176270]) and An-
gelman syndrome (AS [MIM 105830]) are neurogenetic
disorders caused by the loss of function of oppositely
imprinted genes in the chromosomal region 15q11-q13
(for review, see Nicholls and Knepper 2001). Most of
the patients with PWS and AS have a de novo deletion
of 15q11-q13, uniparental disomy, or, in AS, a UBE3A
mutation. In a few patients (1% in PWS and 2%–4%
in AS), the disease is due to aberrant imprinting and
gene silencing. In patients with PWS and an imprinting
defect, the paternal chromosome carries a maternal im-
print, whereas in patients with AS and an imprinting
defect, the maternal chromosome carries a paternal im-
print. In some of these patients, the incorrect imprint is
caused by a microdeletion affecting a bipartite imprint-
ing center (IC) (Buiting et al. 1995). Maternally in-
herited microdeletions affecting an 880-bp region 35
kb proximal to SNURF-SNRPN exon 1 impair the
establishment of the maternal imprint and lead to AS.
Paternally inherited microdeletions affecting a 4.3-kb
region around exon 1 of SNURF-SNRPN impair the
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maintenance of the paternal imprint during early em-
bryogenesis and lead to PWS (El-Maarri et al. 2001).
The shortest regions of deletion overlap for each syn-
drome have been called “AS-SRO” and “PWS-SRO,”
respectively.
We and others (Bu¨rger et al. 1997; Buiting et al. 1998;
Ohta et al. 1999a) have shown that IC deletions cannot
account for all imprinting defects in patients with AS
or PWS. Here, we describe the detailed analysis of 1100
patients.
Material and Methods
Patients
AS or PWS was diagnosed in all patients after ex-
amination by experienced clinicians. Biparental inheri-
tance of the PWS/AS region was shown by microsatellite
analysis. Methylation analysis of the SNURF-SNRPN
exon 1 region revealed that the patients with PWS have
a maternal methylation pattern, and the patients with
AS have a paternal methylation pattern. These findings
classify the patients as having an imprinting defect. In
the present study, a subset of the patients with AS and
an imprinting defect were originally thought to have
PWS. These patients may belong to the subgroup of
patients with AS imprinting defect whose phenotype
overlaps with PWS (Gillessen-Kaesbach et al. 1999).
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Table 1
Distribution of Mutation Status among Patients with AS and PWS
MUTATION
STATUS
NO. (%) OF PATIENTS WITH
AS PWS
IC 9a,b (10) 7c (14)
No IC 76d (80) 44e (86)
Total 85 51
a Includes eight patients with an IC deletion and one patient with
an inversion.
b Includes seven patients reported before (Buiting et al. 1995, 2000;
Ohta et al. 1999).
c Includes five patients reported before (Buiting et al. 1995, 1999,
2001; Saitoh et al. 1997; Ohta et al. 1999a).
d Includes 17 patients reported before (Bu¨rger et al. 1997, 1998).
e Includes 13 patients reported before (Buiting et al. 1998).
DNA Methylation and Southern Blot Analysis
Genomic DNA was purified from whole blood, ac-
cording to standard methods. Methylation at the SNURF-
SNRPN locus was investigated by the methylation-spe-
cific (MS) SNURF-SNRPN PCR (Zeschnigk et al. 1997).
To investigate the grandparental origin of the incorrectly
imprinted chromosome, a combined RFLP/methylation
Southern blot analysis was performed for the SNURF-
SNRPN intron 1 region by use of probe 17 and DNA
digested with BglII  MspI and BglII  HpaII (Buiting
et al. 1998; Ohta et al. 1999b). Deletion screening of
the PWS-SRO and AS-SRO was performed by quan-
titative Southern blot analysis with probes kb17 on
BglII-digested DNA (Buiting et al. 1998) and IC3/
RN285 on EcoRV-digested DNA (Schumacher et al.
1998), respectively. Aliquots of the DNA (2–3 mg) were
digested with the appropriate restriction enzyme, re-
solved on 1% agarose gels, and analyzed by Southern
blot hybridization. As internal standards, hybridization
probes from the retinoblastoma locus on chromosome
13 and the tricho-rhino-phalangeal syndrome locus on
chromosome 8 were used. Probes were labeled by ran-
dom oligonucleotide priming and a-[32P] dCTP (NEN
Dupont). Autoradiography was performed at 80C
with intensifying screens and Kodak XAR films.
Sequence Analysis of PWS-SRO (SNURF-SNRPN Exon
1/Intron 1 Region) and AS-SRO
A 1,185-bp PCR product for the AS-SRO was am-
plified using primers IC16 and MOP3. For the SNURF-
SNRPN exon 1 region, a 344-bp PCR product span-
ning exon 1 was amplified using primers SNRPNe1
and DD40. For the SNURF-SNRPN intron 1 region, a
309-bp PCR product obtained with primers SNRPNi1
and SNRPNi2 was analyzed. PCR products were pu-
rified with Microcon-100 microconcentrators (Amicon).
Sequencing reactions were performed using fluorescence-
tagged dideoxynucleotides and the Taq cycle sequencing
procedure (ABI). Sequences were analyzed on an ABI
377A or ABI 3100 DNA Sequencer.
Methylation Analysis in Sperm DNA Samples
For methylation analysis of the HpaII site at the PW71
locus, sperm DNA was digested with NciI, SpeI, and
HpaII, resolved on a 1% agarose gel, and probed with
u1A800 (Fa¨rber et al. 1999). Methylation analysis of
the HpaII site at the AS-SRO was performed by anHpaII
digest of two sperm DNA samples including a plasmid
as a digest control. Completion of the digest was also
proved by Southern blot methylation analysis at SNURF-
SNRPN exon 1. Undigested, methylated DNA was am-
plified using primer pairs IC16 and MOP3, purified with
Qiagen PCR purification kit, and cloned into a pGemT
plasmid vector (Pharmacia). Clones were sequenced us-
ing vector-specific primers sp6 and T7.
Primer Sequences
Primer sequences for the ICs were as follows: IC16,
5′ GCT CAA GCC GTG TTT CAT TTT 3′; MOP3, 5′
TTG GCT TCC TTT ATA TGA AC 3′; SNRPNe1, 5′
TCT AGA GGC CCC CTC TCA TT 3′; DD40, 5′ GCT
CCC CAG GCT GTC TCT TG 3′; SNRPNi1, 5′ GGT
GCA GTG GTA AGG AGA GG 3′; and SNRPNi2, 5′
AAA GCA GTA GCC CAG TGC AG 3′.
Results and Discussion
Search for IC Deletions
During the past seven years we obtained blood or
DNA samples from 136 unrelated patients with an im-
printing defect. Fifty-one patients had PWS, and 85 pa-
tients had AS. We first searched for an IC deletion by
quantitative Southern blot analysis of the AS-SRO in the
patients with AS and the PWS-SRO in the patients with
PWS. In families with PWS, the fathers were also in-
cluded in the methylation analysis, since an aberrant
methylation pattern would directly indicate a familial IC
deletion. We detected an IC deletion on the paternal
chromosome in seven (14%) patients with PWS and on
the maternal chromosome in eight (9%) patients with
AS (table 1). In most cases, the IC deletion was familial.
In five PWS cases, the father carried the IC deletion on
his maternal chromosome. In one PWS case, the father
did not have the deletion in his blood cells, and thus it
was either de novo or a consequence of a germline mo-
saicism. In another PWS case, parental DNA samples
were not available. In five AS cases, the mother carried
the IC deletion on her paternal chromosome. In two AS
cases, the deletion was either de novo or the result of a
germline mosaicism. In another family, the disease is due
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Table 2
Allele Frequency of Polymorphisms inside the AS-SRO and
SNURF-SNRPN Exon 1/Intron 1 Region in Unaffected
Unrelated Individuals
Region
and Position Polymorphism
Allele
Frequency
AS-SRO:
bp 6152 A/G .84/.16a
bp 6219 G/A .81/.19a
bp 6284 A/C .98/.02a
bp 6311–6314 ins/del TAT .84/.16a
bp 6464 C/G .97/.03a
bp 6525–6526 ins Tb …
bp 6558 G/T .93/.07a
bp 6830 C/T .83/.17a
SNURF-SNRPN:
bp 15006 G/C .94/.06c
bp 15082–15085 ins/del GGAG .99/.01c
bp 15138 G/C .99/.01c
bp 15198 G/Ad …
bp 15233 G/C .99/.01c
SNURF-SNRPN:
bp 16726 A/T .42/.58e
bp 16792 ins/del GTGGGGCGAGAC .95/.05e
bp 16884 A/T .97/.03e
bp 16915 G/Cf …
a Frequency based on 58 chromosomes.
b Present only in one patient with AS and his father.
c Frequency based on 126 chromosomes.
d Present only in one patient with PWS, his mother, and one
patient with AS.
e Frequency based on 38 chromosomes.
f Present only in one patient with PWS and his mother.
to an inversion, with one breakpoint inside the IC region
(Buiting et al. 2000).
Among patients with an IC deletion, three with PWS
and three with AS have at least one affected sib. In con-
trast, none of the patients with a non-IC deletion has
an affected sib. As reported elsewhere (Buiting et al.
1998), at least two patients with PWS and no IC deletion
share the same paternal chromosome 15q11-q13 hap-
lotype with an unaffected sib. Likewise, three patients
with AS and no IC deletion reported elsewhere (Bu¨rger
et al. 1997; Buiting et al. 1998) and four heretofore
unreported patients with AS share the same maternal
chromosome 15 haplotype with an unaffected sib. These
observations suggest that it is unlikely that the imprint-
ing defect in families with PWS and AS and no IC de-
letion is due to a familial mutation.
Sequence Analysis of the AS-SRO
To search for very small deletions or point mutations,
we performed sequence analysis of the AS-SRO plus
flanking regions in 66 patients with AS and no IC de-
letion, including 20 patients from previous studies (Buit-
ing et al. 1998; Gillessen-Kaesbach et al. 1999). Inside
the 1,185-bp sequence, seven different sequence varia-
tions could be detected. One of these variations has been
reported before to be an SNP (Ohta et al. 1999a) and
leads to the presence or absence of a BstN1 restriction
site. Five of the newly identified variants were also found
in 29 control individuals, suggesting that they represent
neutral polymorphisms (table 2). One T insertion (bp
6525–6526 [GenBank accession number AF148319])
found in patient ASID-28 was not present in any of the
control samples. Sequence analysis of the parents’ DNA
revealed that this single-nucleotide insertion is also pre-
sent in the patient’s father and therefore is unlikely to
represent a mutation. Except for these polymorphisms,
no small deletions, point mutations, or structural rear-
rangements inside the AS-SRO could be detected. Of the
66 patients, 45 were found to be heterozygous for at
least one of the polymorphisms; this excludes a deletion
of the AS-SRO and confirms the results obtained by
quantitative Southern blot analysis.
Sequence Analysis of the PWS-SRO
In 32 patients with PWS and no IC deletion, including
9 patients reported elsewhere (Buiting et al. 1998), we
sequenced two regions of the PWS-SRO. First, we an-
alyzed a 344-bp PCR product containing the SNURF-
SNRPN exon 1 and promoter. As shown by Schweizer
et al. (1999), this region contains an HpaII site that is
subject to nuclease hypersensitivity in a parent-of-ori-
gin–specific manner. In contrast to the AS-SRO, this
region seems to be highly conserved, because only two
rare single-nucleotide variations could be detected. In
7 of the 32 patients with PWS, a heterozygous CrG
exchange was found at position 83 of exon 1 (bp
15006 3′–5′ orientation [GenBank accession number
AC009696]). This variation was also found in 7 of 68
control samples in a heterozygous state, suggesting that
this variation represents an SNP. In one patient (PWSID-
04), a GrA exchange at position 4 of exon 1 (bp
15198 in AC009696 3′–5′ orientation) was found. This
transition was not detected in any of the control subjects
but was found in the patient’s mother and in a patient
with AS and no IC deletion (ASID-03). Thus, this single-
nucleotide exchange also seems to be a rare neutral
variant.
Second, we analyzed 309 bp spanning an HpaII site
∼2 kb distal to exon 1, which has previously been shown
to be subject to nuclease hypersensitivity in a parent-of-
origin–specific manner (Schweizer et al. 1999); 19 con-
trol individuals were included in this analysis. Again, we
found no evidence of a structural or point mutation in
any of the patients but observed heterozygosity in 22
patients for at least one of three newly identified SNPs,
confirming that these patients have no deletion of the
PWS-SRO. Only one patient (PWSID-04) showed a
heterozygous GrC exchange (at position 16915 in
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Figure 1 Mosaic methylation defect. A, (MS)-PCR analysis of
SNURF-SNRPN exon 1 in two patients with AS and an imprinting
defect. Patient ASID-56 shows a typical AS methylation pattern,
whereas patient ASID-55 has a faint methylated band. A faint meth-
ylated band (arrow) is also detected by MS Southern blot analysis. B,
meth p methylated; unmeth p unmethylated; F p father; M p
mother; B p BamHI; H p HpaII; M p MspI. In contrast to HpaII,
MspI is not MS.
Table 3
Grandparental Origin of the Chromosome Carrying the
Imprinting Defect
Origin
AS PWS
IC
Mutation
No IC
Mutation
IC
Mutation
No IC
Mutation
Maternal:
Grandfather 5a 7 0 0
Grandmother 1a 11 0 0
Paternal:
Grandfather 0 0 1b 0
Grandmother 0 0 4a 19c
a In one patient, the deletion is de novo or due to a germline
mosaicism.
b In one patient, the father is mosaic for the deletion.
c Significantly different from equal grandpaternal and grandma-
ternal inheritance ( ).Pp .000002
AC009696, 3′–5′ orientation), which was not present in
any other patient or the control group. Analysis of the
parents’ DNA revealed that this variation is also present
in the patient’s mother and therefore appears to be a
rare variant.
Mosaic Methylation Defects in Patients with AS
Imprinting Defect
In five of the seven atypical non–IC-deletion patients
with AS with an imprinting defect who were reported
by Gillessen-Kaesbach et al. (1999), a faint maternal
band, indicative of methylation mosaicism, had been ob-
served by use of MS-PCR analysis for the SNURF-
SNRPN exon 1 region. In the present study we found
such a weak maternal band in 6 additional patients with
atypical AS and no IC deletion but also in 10 patients
with typical symptoms of AS (total, 27% of patients).
In some of these patients, methylation analysis of an
HpaII site inside intron 1 of SNURF-SNRPN by South-
ern blot hybridization showed the same result, thus ex-
cluding an MS-PCR–based artifact (fig. 1). We never
observed a weak maternal band in patients with AS with
a common large deletion, uniparental disomy, or IC de-
letion. Thus, this finding seems to be restricted to pa-
tients with an imprinting defect and no IC deletion.
Methylation mosaicism is much rarer in patients with
PWS and no IC deletion. In the present study, a faint
paternal band was present in only 2 of 44 patients
(PWSID-06 and PWSID-17). In one of these patients,
we could also detect the band by Southern blot analysis
(data not shown).
Grandparental Origin of the Chromosome Carrying the
Imprinting Defect
To investigate the grandparental origin of the incor-
rectly imprinted chromosome, we performed microsat-
ellite analysis or used a combined methylation/RFLP test
for the SNURF-SNRPN locus (Buiting et al. 1998). In
the patients with AS and no IC deletion, the maternal
chromosome carrying an incorrect paternal imprint was
inherited from the maternal grandfather in 11 patients
and from the maternal grandmother in 7 patients. This
finding suggests that the imprinting defect occurred after
erasure of the parental imprints, possibly even only after
fertilization, as discussed above. In contrast, in 19 in-
formative patients with PWS and no IC deletion, the
paternal chromosome carrying an incorrect maternal
imprint was always derived from the paternal grand-
mother (table 3). This bias was highly significant
( ). We can think of three explanations forPp .000002
this bias.
(1) The patients carry an unidentified IC mutation. If
this were the case, we would expect to find affected sibs
in this group of patients. As mentioned above, however,
all patients with no IC deletion have sporadic disease,
and some of them even share a paternal haplotype with
an unaffected sib. Although the latter finding may be
explained by germline mosaicism, we consider this pos-
sibility to be unlikely.
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Figure 2 Methylation analysis of sperm DNA samples at D15S63 (PW71) and the AS-SRO A, Methylation analysis in different sperm
samples with probe PW71 on DNA digested with HindIII  HpaII (top). In all sperm samples a methylated and an unmethylated band is
present. Results are shown for methylation analysis in two sperm samples heterozygous for an NciI restriction site polymorphism (NciI*) at
the D15S63 locus (middle). The different possible fragments for the methylated and unmethylated allele I and allele II are shown in the map
below (not drawn to scale). The Southern blot (middle) shows the presence of a methylated and an unmethylated fragment for both alleles. B,
Sequence analysis of two sperm DNA samples heterozygous for one or two SNPs inside the AS-SRO. Both sperm DNA samples were digested
with HpaII and amplified with primers flanking the HpaII site. If methylation at this locus is allele specific, only the methylated allele should
be amplified. By cloning the PCR products from sperm sample 1096, we obtained 11 clones from one allele and 14 from the other. For sperm
sample 16, we obtained 11 clones from one allele and 12 clones from the other.
(2) The parental identity of the two homologues is
maintained during male germ cell development. By an-
alyzing the ontogeny of the H19 imprint in the mouse,
Davis et al. (2000) have recently found that the reestab-
lishment of the imprints on the parental alleles occurs
at different times in male germ cell development.
Whereas the paternal H19 allele becomes methylated
during fetal stages, methylation of the maternal allele
begins during perinatal stages and continues after birth
through the onset of meiosis. We reasoned that certain
CpG dinucleotides in human 15q11-q13 might be dif-
ferentially methylated in spermatozoa and might occa-
sionally become inadvertent nucleation sites for a ma-
ternal imprint. As shown elsewhere (e.g., El-Maarri et
al. 2001), we found that most CpGs have a paternal
methylation pattern in sperm. Interestingly, however, one
HpaII site at the D15S63 (PW71) locus and one HpaII
site just proximal of the AS-SRO showed ∼50% meth-
ylation (fig. 2A). The latter HpaII site, as well as other
CpGs of the AS-SRO region, are heavily methylated in
blood (Schumacher et al. 1998). To find out if methyl-
ation of the two HpaII sites is allele specific or random,
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we used two different approaches. For the D15S63 lo-
cus, we used a combined RFLP/methylation analysis.
First, we screened for a sperm DNA sample informative
for an NciI polymorphism (Dittrich et al. 1993) close to
the HpaII site. Two heterozygous sperm samples (sample
902 and 797) were then used for Southern blot analysis.
The DNA was digested with SpeI  HpaII  NciI (fig.
2A) and was probed with u1A800 (Fa¨rber et al. 1999).
Because both parental alleles in sperm samples 902 and
797 are partially digested by HpaII, methylation is not
allele specific.
For the HpaII site at the AS-SRO, we used two sperm
DNA samples that are heterozygous for one or two SNPs
inside the AS-SRO, close to the HpaII site. We digested
both sperm DNA samples with HpaII and performed
PCR with primers flanking the HpaII site. If methylation
at this locus were allele specific, only the methylated
allele should be amplified. By cloning the PCR products,
we obtained 23 clones for sperm sample 16 and 25
clones for sperm sample 1096. Given that both parental
alleles were recovered (fig. 2B), methylation is not allele
specific. A similar result was obtained for brain DNA
(data not shown). Although we cannot exclude allele-
specific DNA methylation at other loci (or parental im-
prints other than DNA methylation), there is no indi-
cation that the parental identity of the two homologues
is maintained in mature spermatozoa.
(3) The incorrect maternal imprint in the patients re-
sults from a failure of the paternal germline to erase the
grandmaternal imprint (epigenetic inheritance). There is
increasing evidence to suggest that epigenetic marks at
some mammalian alleles are not completely erased from
one generation to the next. Morgan et al. (1999) and
Kearns et al. (2000), for example, reported mouse lines
carrying retrotransposons or transgenes that display in-
complete penetrance and variable expressivity dependent
on the parental origin. On the basis of detailed breeding
and methylation studies, it was suggested that the im-
print is not completely erased and reset when passed
through the germline, resulting in unusual patterns of
inheritance of gene expression. Although epigenetic in-
heritance of endogenous genes has not been reported in
mammals, it is well known in other species. We propose
that it occurs at a low frequency in 15q11-q13 and pos-
sibly at other human loci as well. Assuming that PWS
occurs in 1/15,000 newborns and that 1% of patients
have a non–IC-deletion imprinting defect, 1/1,500,000
spermatozoa should carry a maternal imprint that was
not erased in the paternal germline. It will be a formi-
dable task to detect such a cell.
Conclusions
In summary, by analyzing a very large series of patients
with an imprinting defect and PWS or AS, we have de-
termined that the vast majority of these defects are epi-
mutations (aberrant epigenetic states) that occurred
spontaneously in the absence of DNA sequence changes.
The apparent absence of point mutations may indicate
that the IC can tolerate small sequence changes or that
it contains multiple, redundant elements. Epimutations
of the maternal chromosome are often present in a mo-
saic form. This suggests that, in these patients, aberrant
DNA methylation occurred after fertilization, when the
maternal CpG methylation pattern is established (El-
Maarri et al. 2001). Nevertheless, the underlying defect
may be pre- or postzygotic. It is possible, for example,
that the primary gametic imprint (which may be histone
H3 lysine 9 methylation [Xin et al. 2001] or some other
chromatin modification) is not always stable, that it is
not always faithfully translated into CpG methylation,
or that CpG methylation is not always faithfully repli-
cated during early embryogenesis. It may be speculated
that the frequency of these failures and the degree of
mosaicism are influenced by the genetic or epigenetic
background.
Methylation mosaicism makes it difficult to predict
the phenotype. In fact, the clinical spectrum among
these patients is very broad and ranges from typical AS,
through mild AS, to atypical AS. All mosaic patients
have a very low level of normal cells. This may be an
ascertainment bias, because patients with a higher pro-
portion of normal cells are likely to have a very mild
phenotype and to escape clinical detection.
Epimutations of the paternal chromosome appear to
occur during male germ cell development and to lead
to epigenetic inheritance, that is, the inheritance of an
epigenetic state from one generation to the next. The
significance of epigenetic inheritance in humans is un-
clear. It is possible, however, that it is not only a curi-
osity in PWS but a contributor to genetic variation in
humans (Rakyan et al. 2001).
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